For women experiencing depression due to the cancer and hot flashes due to tamoxifen it is important not to prescribe SSRIs and SNRIs, which are moderate to strong CYP2D6 inhibitors and decrease endoxifen levels by 50–72% [103]. This evidence concerns the gene CYP2D6 and major depressive disorder.